SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001144204-14-046055
Filing Date
2014-07-31
Accepted
2014-07-31 14:55:32
Documents
13

Document Format Files

Seq Description Document Type Size
1 424B4 v385229_424b4.htm 424B4 2107052
2 GRAPHIC logo_bioblast.jpg GRAPHIC 16779
3 GRAPHIC spacer.gif GRAPHIC 43
4 GRAPHIC line.gif GRAPHIC 43
5 GRAPHIC v378842_chrt-shade.jpg GRAPHIC 32347
6 GRAPHIC v378842_chrt-trehalose.jpg GRAPHIC 23230
7 GRAPHIC v371611_chrt-bar.jpg GRAPHIC 21047
8 GRAPHIC v378842_chrt-rationale.jpg GRAPHIC 20786
9 GRAPHIC v371611_chrt-barcells.jpg GRAPHIC 33452
10 GRAPHIC v371611_chrt-barcells1.jpg GRAPHIC 39466
11 GRAPHIC v378842_chrt-tbl1.jpg GRAPHIC 143076
12 GRAPHIC v378842_chrt-tbl2.jpg GRAPHIC 165572
13 GRAPHIC logo_ey-motto.jpg GRAPHIC 6667
  Complete submission text file 0001144204-14-046055.txt   2802203
Mailing Address 35 AHAD HA'AM ST TEL AVIV L3 65202
Business Address 35 AHAD HA'AM ST TEL AVIV L3 65202 972 (0) 3 7326616
BIO BLAST PHARMA LTD. (Filer) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-193824 | Film No.: 141005910
SIC: 2834 Pharmaceutical Preparations